Pay in 4 interest-free payments of $4687.50 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
Gracias al doble listado (de santos y de atributos)
A través de un diseño transversal y comparativo que involucra a 88 KTR y 81 controles
Martha Patrica Acero Bautista e Carlos Suárez Sanz
Un abordaje atrayente hecho con precisión y objetividad
Refining Processes for the Co-Development of Genome-Based Therapeutics and Companion Diagnostic Tests Myths of PR Gracias al doble listado (deRefining Processes for the Co Development of Genome Based Therapeutics and Companion Diagnostic Tests Many drug developers have examined new strategies for creating efficiencies in their development processes, including the adoption of genomics based approaches. Genomic data can identify new drug targets for both common and rare diseases, can predict which patients are likely to respond to a specific treatment, and has the potential to significantly
US$ 195.00
US$ 135.00
US$ 117.00
US$ 5397.00
US$ 2100.00